References
- Vissink A, Panders AK, Gravenmade EJ, et al. The causes and consequences of hyposalivation. Ear Nose Throat 1988;67:166-176
- Yeh CK, Johnson DA, Dodds MW. Impact of aging on human salivary gland function: a community based study. Aging 1998; 10:421-428
- Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors following parotid-sparing irradiation of head-andneck cancer. Int J Radiat Oncol Biol Phys 2001;50:695-703 https://doi.org/10.1016/S0360-3016(01)01512-7
- Jen YM, Shin R, Lin YS, et al. Parotid gland-sparing 3- dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy. Radiother Oncol 2005;75:204-209 https://doi.org/10.1016/j.radonc.2005.03.005
- Braam PM, Roesink JM, Moerland MA, et al. Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys 2005;50:695-703
- Lim JH, Kim GW, Keum KC, et al. Parotid sparing radiotherapy technique using 3-D conformal radiotherapy for nasopharyngeal carcinoma. J Korean Soc Ther Radiol Oncol 2000; 18:1-10
- Malouf JG, Aragon C, Henson BS, et al. Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients. Cancer Detection and Prevention 2003;27: 305-310 https://doi.org/10.1016/S0361-090X(03)00095-3
- Chao KSC, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head and neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;51:938-946 https://doi.org/10.1016/S0360-3016(01)01717-5
- Ng MK, Porceddu SV, Milner AD, et al. Parotid-sparing Radiotherapy: does it really reduce xerostomia? Clin Oncol 2005;17:610-617 https://doi.org/10.1016/j.clon.2005.06.012
- Lee SH, Kim TH, Chie EK, et al. Evaluation of xerostomia following intensity modulated radiotherapy (IMRT) for head and neck cancer patients. J Korean Soc Ther Radiol Oncol 2004; 22:106-114
- Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma. Cancer 2004;101:1584-1593 https://doi.org/10.1002/cncr.20552
- Amosson CM, Teh BS, Van TJ, et al. Dosimetric predictors of xerostomia for head and neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. Int J Radiat Oncol Biol Phys 2003;56:136- 144 https://doi.org/10.1016/S0360-3016(03)00093-2
- Wu Q, Manning M, Schmidt-Ullirich R, et al. The potential for sparing of parotids and escalation of biologically equivalent dose with intensity modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000;46:195-205 https://doi.org/10.1016/S0360-3016(99)00304-1
- Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-1317 https://doi.org/10.1200/JCO.1998.16.4.1310
- Chan AT, Teo PM, Ngan RK, et al. Concurrent chemotherapy- radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progressionfree survival analysis of a phase III randomized trial. J Clin Oncol 2002;20:2038-2044 https://doi.org/10.1200/JCO.2002.08.149
- Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 2003;21:631-637 https://doi.org/10.1200/JCO.2003.06.158
- Kwong DL, Sham JS, Au GK, et al. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol 2004;22:2643-2653 https://doi.org/10.1200/JCO.2004.05.173
- Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with AJCC/UICC (1997) stage 3 and 4 nasopharyngeal cancer of the endemic variety. J Clin Oncol 2005;23:6730-6738 https://doi.org/10.1200/JCO.2005.16.790
- Yeh SA, Tang Y, Lui CC, et al. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 2005;62:672-679 https://doi.org/10.1016/j.ijrobp.2004.11.002
- Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 1994;28:847-856 https://doi.org/10.1016/0360-3016(94)90104-X
- Franzen L, Funegard U, Ericson T, et al. Parotid gland function during and following radiotherapy of malignancies in the head and neck: a consecutive study of salivary flow and patient discomfort. Eur J Cancer 1992;28:457-462 https://doi.org/10.1016/S0959-8049(05)80076-0
- Marks JE, Davis CC, Gottsman VL, et al. The effects of radiation on parotid salivary function. Int J Radiat Oncol Biol Phys 1981;7:1013-1019 https://doi.org/10.1016/0360-3016(81)90152-8
- Longma LP, Highman SM, Bucknall R, et al. Signs and symptoms in patients with salivary gland hypofunction. Postgrad Med J 1997;73:93-97 https://doi.org/10.1136/pgmj.73.856.93
- Kosuda S, Satoh M, Yamamoto F, et al. Assessment of salivary gland dysfunction following chemoradiotherapy using quantitative salivary gland scintigraphy. Int J Radiat Oncol Biol Phys 1999;45:379-384 https://doi.org/10.1016/S0360-3016(99)00166-2
- Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al. Development of European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients: EORTC Quality of Life Study Group. Acta Oncol 1994;33:897- 885
- Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-579 https://doi.org/10.1200/JCO.1993.11.3.570
- Eisbruch A, Kim HM, Ten Haken R, et al. Dose, volume and function relationships in parotid glands following conformal and intensity modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1996;45:577-587